Additionally they showed that CD4CD25bright cells of patients with active RA expressed high levels of TNF receptor II, reduced levels of FOXP3 and were poor suppressors, which could be reversed by anti- TNFα treatment[13]. This evidence concerns the gene FOXP3 and rheumatoid arthritis.